BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

QIAGEN N.V. (QGEN) Launches Free iPhone and iPad App


11/16/2010 1:18:00 PM

Hilden, Germany, and Germantown, MD – November 16th, 2010 – Today QIAGEN launched the free QIAGEN App, an application that can be used on iPhone and iPad mobile devices with tables of commonly used lab buffers and solutions as well as a variety of conversion and dilution calculators, all aimed at easing scientists’ daily work.

QIAGEN App allows users to watch more than 20 video tutorials on the iPhone and iPad on innovative technologies in many application areas such as automation, gene expression analysis, genotyping and pyrosequencing. The iPad application will offer a bundle for QIAcube users that includes protocol sheets, support documents and updates. QIAGEN App can be downloaded at www.qiagen.com/support/qiaapps/default.aspx or found in the Support - Tips & Tools section on www.qiagen.com and will be regularly updated and extended with other apps following soon. iPhone and iPad are trademarks of Apple Inc. Use of these marks does not imply any endorsement by or affiliation with Apple.

For a high resolution image, please contact us at pr@qiagen.com.

About QIAGEN

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make these isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The Company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the first FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.

Contact:

Global: Dr. Marc Egelhofer QIAGEN GmbH +49-2103-29-11741 e-mail: marc.egelhofer@qiagen.com

US: Cassie Knapp QIAGEN +1-240-686-7686 e-mail: cassie.knapp@qiagen.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES